LINEZOLID RM linezolid 600 mg tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

linezolid, Quantity: 600 mg

Available from:

Amneal Pharma Australia Pty Ltd

INN (International Name):

Linezolid

Pharmaceutical form:

Tablet

Composition:

Excipient Ingredients: magnesium stearate; titanium dioxide; silicon dioxide; croscarmellose sodium; hypromellose; diethyl phthalate; microcrystalline cellulose; povidone; purified talc; ethylcellulose

Administration route:

Oral

Units in package:

10, 30

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Linezolid is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,Linezolid is active against Gram-positive bacteria only. It has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram- negative pathogen is documented or suspected.

Product summary:

Visual Identification: White to off white, oval shaped, film coated tablets, debossed with AI006 on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-06-01